A retrospective clinical study of the safety and efficacy of AFA mixture, an herbal antihypertensive product

Document Type: Original article

Authors

1 Herbal Medicine Unit, Tafo Government Hospital, Kumasi, Ghana Health Service, Ghana;

2 Maternal and Child Health Hospital, Kumasi, Ghana;

3 Afrancho Health Centre, Kumasi, Ghana;

Abstract

Background & Aim: Hypertension is an incurable disease which has become a common major risk factor for many cardiovascular diseases worldwide. Besides increasing the risk of heart diseases and stroke, hypertension can also lead to other health conditions such as renal disease and diabetes. The prolong use of orthodox antihypertensive are usually associated with many side effects coupled with the millions of dollars spent annually for the treatment and detection of heart diseases. However, herbal products with antihypertensive properties offer an alternative and effective way to decrease the rising number of people with hypertension. AFA Mixture is a bi-herbal antihypertensive product on the essential herbal medicine list of the Ministry Of Health of Ghana, used at the pilot centers by Medical Herbalists for about eight years, for the management of hypertension. It is composed of the aqueous stem back extract of Rauwolfia vomitoria and Alstonia boonei.
Experimental: This study reports on the retrospective clinical study of AFA Mixture, for hypertensive patients reporting at Tafo Government Hospital, Herbal Medicine Unit. Data on two hundred (200) patients who were diagnosed of hypertension from January 2018 to June 2018 were assessed.
Results: The results indicated a decline in both systolic and diastolic blood pressure, with a mean systolic pressure of 130 mmHg from an initial reading of 160mmHg and a mean diastolic pressure of 90 mmHg from an initial reading of 110mmHg. Kidney and liver function tests were within normal range at the end of the study.





Recommended applications/industries: It was concluded that AFA Mixture could be safe and effective in the management of hypertension in motivated clients.

Keywords


Article Title [Persian]

مطالعه بالینی در مورد ایمنی و کارآیی مخلوط AFA، محصول ضد قارچ گیاهی

Authors [Persian]

  • برنارد کوفی ترکسان 1
  • اگنس ابوگی 1
  • پل اوسی کوفی 1
  • تونی منسا 1
  • اچاب امنوئل 1
  • یونه ویوم 2
  • عربا یامونکا ترکسان 3
Abstract [Persian]

Background & Aim: Hypertension is an incurable disease which has become a common major risk factor for many cardiovascular diseases worldwide. Besides increasing the risk of heart diseases and stroke, hypertension can also lead to other health conditions such as renal disease and diabetes. The prolong use of orthodox antihypertensive are usually associated with many side effects coupled with the millions of dollars spent annually for the treatment and detection of heart diseases. However, herbal products with antihypertensive properties offer an alternative and effective way to decrease the rising number of people with hypertension. AFA Mixture is a bi-herbal antihypertensive product on the essential herbal medicine list of the Ministry Of Health of Ghana, used at the pilot centers by Medical Herbalists for about eight years, for the management of hypertension. It is composed of the aqueous stem back extract of Rauwolfia vomitoria and Alstonia boonei.
Experimental: This study reports on the retrospective clinical study of AFA Mixture, for hypertensive patients reporting at Tafo Government Hospital, Herbal Medicine Unit. Data on two hundred (200) patients who were diagnosed of hypertension from January 2018 to June 2018 were assessed.
Results: The results indicated a decline in both systolic and diastolic blood pressure, with a mean systolic pressure of 130 mmHg from an initial reading of 160mmHg and a mean diastolic pressure of 90 mmHg from an initial reading of 110mmHg. Kidney and liver function tests were within normal range at the end of the study.
Recommended applications/industries: It was concluded that AFA Mixture could be safe and effective in the management of hypertension in motivated clients.

Keywords [Persian]

  • Retrospective clinical study
  • Cardiovascular
  • Hypertension
  • Herbal medicine
  • Medical Herbalists
Antihypertensive. A Guide to Prescribing. 2018.

Anyanwu, G.O., Onyeneke, C.E., Iqbal, J., Qamar, M. U.D., Khan, S.U., Rehman, S.U., Rauf, K. and Rehman, N. U. 2018. Alkaloid fraction of Alstonia Boonei stem bark demonstrate antiobesity potential on high fat diet induced obesity in male Sprague-Dawley rats. 2018. The FASEB Journal. 32(1):840-844.

CDC. High Blood Pressure Fact Sheet. 19th February, 2015. https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm.

Forney and Barbara (2001-2002). Reserpine for Verterinary Use. Wedgewood Pharmacy. https://www.wedgewoodpetrx.com/learning-center/-professional-monographs/reserpine-for-veterinary-use.html

Ojewole, J.A.O. 1984. Studies on the pharmacology of echitamine, an alkaloid from the stem bark of Alstonia boonei L. (Apocynaceae). International Journal of Crude Drug Research, 22(3): 121-143.

Naish, J., Court, D.S. 2014. Medical Sciences 2ed. Elsevier Health Sciences. Pp. 562.

Jerie, P. 2007. Milestones of cardiovascular therapy, IV. Reserpine. Cas Lek Cesk; 146(7): 573-577.

Kucera, M., Marquis, V.O. and Kucerovah. 1972. Contribution to the knowledge on Nigerian medicinal plants. TLC separation and quantitative evaluation of Alstonia Alkaloids. Planta Medica, 21:343-346.

Lackland, D.T., Weberm, M.A. 2015. Global burden of cardiovascular disease and stroke; hypertension at the core. The Canadian Journal of Cardiology. 31 (5): 569-71.

Maurice, M.I. 1993. Handbook of African medicinal plants. CRC Press, Boca Raton, FL, Pp.116-118.

Whelton, P.K., Carey, R.M., Aronow, W.S., Casey, D.E., Collins, K.J., Jamerson, K.A., Jones, D.W., MacLaughlin, E.J., Munter, P., Ovbiagele, B., Smith, S.C., Spencer, C.C., Stafford, R.S., Taler, S.J., Thomas, R.J., Williams, K.A., Wiilliams, J.D., Wright, J.T. 2017. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Journal of the American College of Cardiology, 71(6), 1269-1324.

World Health Organization. 2017.www.who.int/ cardiovascular_diseases/about_cvd/en/. Accessed December 09, 2018.